0.0800
-0.0300
(-27.27%)
At close: January 23 at 7:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-2,781.0000
-4,057.0000
-5,205.0000
-9,820.0000
-10,037.0000
Investing Cash Flow
--
-3.0000
--
-6.0000
-13.0000
Financing Cash Flow
2,746.0000
2,727.0000
5,778.0000
7,045.0000
8,422.0000
End Cash Position
2,707.0000
-70.0000
-1,403.0000
-830.0000
3,611.0000
Capital Expenditure
--
-3.0000
--
-6.0000
-13.0000
Issuance of Capital Stock
2,005.0000
1,150.0000
6,007.0000
7,283.0000
8,687.0000
Repayment of Debt
-9.0000
-173.0000
-229.0000
-238.0000
-265.0000
Free Cash Flow
-2,781.0000
-4,060.0000
-5,205.0000
-9,826.0000
-10,050.0000
12/31/2020 - 11/26/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDNAF Medicenna Therapeutics Corp.
0.9380
-3.30%
DYAI Dyadic International, Inc.
1.4700
-4.55%
PHRM.CN PharmaTher Holdings Ltd.
0.2300
+4.55%
CLGN CollPlant Biotechnologies Ltd.
3.7100
-6.08%
NGENF NervGen Pharma Corp.
1.9600
-2.00%
BCDA BioCardia, Inc.
2.1900
+0.46%
ONCO.CN Onco-Innova
2.5500
+15.91%
SABS SAB Biotherapeutics, Inc.
4.1000
+12.48%
ABEO Abeona Therapeutics Inc.
5.26
+0.19%
ANNX Annexon, Inc.
4.1300
-2.59%